ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,035.69
-1.57%
US Tech 100
16,870.00
-0.67%
다우존스 지수
37,815.92
-1.49%
Bitcoin
57,575.02
-4.99%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Agenus Inc (AGEN)

  7. Agenus Inc (AGEN) 뉴스

AGEN

Agenus (AGEN)

Agenus Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:AGEN
일자시간출처헤드라인심볼기업
2024/04/2423:00Business WireBotensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual MeetingNASDAQ:AGENAgenus Inc
2024/04/2320:30Business WireAgenus to Provide First Quarter 2024 Financial Report and Corporate UpdateNASDAQ:AGENAgenus Inc
2024/04/1220:30Business WireAgenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal CancerNASDAQ:AGENAgenus Inc
2024/04/0605:30Business WireAgenus Announces Reverse Stock Split of Common StockNASDAQ:AGENAgenus Inc
2024/03/1420:30Business WireAgenus Reports Fourth Quarter and Full Year 2023 ResultsNASDAQ:AGENAgenus Inc
2024/03/0621:30Business WireAgenus Announces Preclinical Data on BMS-986442 (AGEN1777) at AACR 2024NASDAQ:AGENAgenus Inc
2024/03/0606:30Business WireAgenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AGENAgenus Inc
2024/03/0106:50Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AGENAgenus Inc
2024/02/2921:30Business WireAgenus to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial ReportNASDAQ:AGENAgenus Inc
2024/02/2706:24Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AGENAgenus Inc
2024/02/2621:30Business WireAgenus to Participate in Leerink Partners Global Biopharma ConferenceNASDAQ:AGENAgenus Inc
2024/02/1522:02Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:AGENAgenus Inc
2024/02/1522:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGENAgenus Inc
2024/02/1521:02PR Newswire (US)Ginkgo Bioworks and SaponiQx Awarded MCDC Contract to Discover and Manufacture Next-Generation Vaccine Adjuvants Using Generative Molecular DesignNASDAQ:AGENAgenus Inc
2024/02/1422:33Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AGENAgenus Inc
2024/02/1221:00Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:AGENAgenus Inc
2024/02/1221:00Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:AGENAgenus Inc
2024/02/1007:11Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AGENAgenus Inc
2024/01/3122:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGENAgenus Inc
2024/01/3121:30Business WireAgenus to Participate in Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:AGENAgenus Inc
2024/01/2223:59Business WireBotensilimab/Balstilimab Breakthrough Data Presented at ASCO-GI Shows Unprecedented Tumor Shrinkage and Robust Biomarker Response in Prevalent Colorectal Cancer PopulationNASDAQ:AGENAgenus Inc
2024/01/2221:30Business WireBotensilimab/Balstilimab Breakthrough Data Presented at ASCO-GI Shows Unprecedented Tumor Shrinkage and Robust Biomarker Response in Prevalent Colorectal Cancer PopulationNASDAQ:AGENAgenus Inc
2024/01/0606:30Business WireAgenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AGENAgenus Inc
2024/01/0421:30Business WireAgenus to Participate in B. Riley Healthcare ConferenceNASDAQ:AGENAgenus Inc
2024/01/0420:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGENAgenus Inc
2024/01/0420:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGENAgenus Inc
2024/01/0420:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGENAgenus Inc
2023/12/2021:30Business WireBotensilimab/Balstilimab Data in Neoadjuvant Colorectal Cancer Selected for ASCO-GI 2024NASDAQ:AGENAgenus Inc
2023/12/1121:30Business WireAgenus to Receive $25 Million Milestone Payment from Bristol Myers Squibb for TIGIT-CD96 Bispecific ProgramNASDAQ:AGENAgenus Inc
2023/12/0906:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGENAgenus Inc
 검색 관련기사 보기:NASDAQ:AGEN

최근 히스토리

PM
XAUUSD
Gold vs US Dollar
NYSE
DIS
Walt Disney
USI
USTECH100
US Tech 100
USOTC
ADDYY
Adidas (QX)
AMEX
XLF
Financial Select Sector
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
AXP
American Express
CCOM
US100
US Tech 100
USOTC
BNPQY
BNP Paribas (QX)
CCOM
US500
US 500
CCOM
SILVER
SILVER
NYSE
MCD
McDonalds
COIN
SOLUSD
Solana
USOTC
BASFY
BASF (QX)
FX
USDJPY
US Dollar vs Yen
NYSE
CVX
Chevron
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유